CRO concept oscillates and rebounds, Zhaoyan's new drug hits limit up.

CRO concept oscillates and rebounds, Zhongyan's new drug hits the limit up, Medici, Kailaiying, Meinohua, Sunshine Nuohao, Pharmaron, Kanglong Huacheng, and other companies follow the rise.